PG
Prostatis Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $288K | Buy |
1,551
+88
| +6% | +$16.3K | 0.08% | 122 |
|
|
2025
Q1 | $307K | Buy |
1,463
+29
| +2% | +$6.08K | 0.1% | 118 |
|
|
2024
Q4 | $255K | Sell |
1,434
-87
| -6% | -$15.5K | 0.07% | 138 |
|
|
2024
Q3 | $300K | Sell |
1,521
-89
| -6% | -$17.6K | 0.1% | 112 |
|
|
2024
Q2 | $276K | Buy |
1,610
+89
| +6% | +$15.3K | 0.1% | 122 |
|
|
2024
Q1 | $277K | Buy |
1,521
+25
| +2% | +$4.55K | 0.11% | 119 |
|
|
2023
Q4 | $232K | Buy |
1,496
+61
| +4% | +$9.46K | 0.1% | 119 |
|
|
2023
Q3 | $214K | Sell |
1,435
-62,081
| -98% | -$9.26M | 0.1% | 106 |
|
|
2023
Q2 | $197K | Buy |
63,516
+62,085
| +4,339% | +$193K | 0.09% | 109 |
|
|
2023
Q1 | $215K | Sell |
1,431
-10
| -0.7% | -$1.5K | 0.11% | 93 |
|
|
2022
Q4 | $233K | Buy |
+1,441
| New | +$233K | 0.14% | 87 |
|